Treatment of hepatitis C virus
US8912141B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 21, 2012 |
| Grant date | Dec 16, 2014 |
| Priority date | — |
| Expiry date | Jun 21, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combined therapy which utilizes hydroxychloroquine and GNS-227:for the treatment of an HCV-related disease, including HCV chronic infection, is disclosed. Further disclosed is pharmaceutical composition (e.g., as a unit dosage form) comprising hydroxychloroquine and GNS-227.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.